Evidence map›Paper›PMID 31040224›Full record

ArticleTobacco control2020

'The lesser devil you don't know': a qualitative study of smokers' responses to messages communicating comparative risk of electronic and combusted cigarettes.

Daniel Owusu, Rachel Lawley, Bo Yang, Katherine Henderson, Brittaney Bethea, Christopher LaRose, Sam Stallworth, Lucy Popova

Open access · greenAbstract read
In one paragraph

Article in Tobacco control, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
11.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Exploring the Underlying Beliefs Shaping Perceptions of E-cigarette Harm Among a Convenience Sample of Adults in the United States.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Smokers' Exposure to Perceived Modified Risk Claims for E-Cigarettes, Snus, and Smokeless Tobacco in the United States.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2021
    Article
  20. Harm Perceptions and Beliefs about Potential Modified Risk Tobacco Products.International journal of environmental research and public health · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Daniel OwusuSchool of Public Health, Georgia State University, Atlanta, Georgia, USA.ORCID 0000-0003-0114-5829
Rachel LawleySchool of Public Health, Georgia State University, Atlanta, Georgia, USA.
Bo YangSchool of Public Health, Georgia State University, Atlanta, Georgia, USA.
Katherine HendersonSchool of Public Health, Georgia State University, Atlanta, Georgia, USA.
Brittaney BetheaDepartment of Communication, Georgia State University, Atlanta, Georgia, USA.
Christopher LaRoseJohn Snow, Inc, Atlanta, Georgia, USA.
Sam StallworthJohn Snow, Inc, Atlanta, Georgia, USA.
Lucy PopovaSchool of Public Health, Georgia State University, Atlanta, Georgia, USA lpopova1@gsu.edu.
Georgia State University · USJohn Snow (United States) · US

Funding

The Science of Decision Making: Connecting People and PolicyP50DA036128 · NIDA · GEORGIA STATE UNIVERSITY · PI ERIKSEN, MICHAEL PAUL · 2013 to 2018
$19.4M
Communicating harm of new tobacco productsR00CA187460 · NCI · GEORGIA STATE UNIVERSITY · PI POPOVA, LYUDMILA · 2016 to 2018
$738k
NCI NIH HHS R00 CA187460NIDA NIH HHS P50 DA036128
6 · The paper itself

Abstract

introductionCommunicating to smokers that e-cigarettes deliver lower levels of harmful chemicals than combusted cigarettes is a challenging issue. This study qualitatively explored smokers' interpretations of messages communicating the risk of e-cigarettes relative to cigarettes (comparative risk messages).

methodWe developed 12 print comparative risk messages and evaluated them in 12 focus groups with 72 adult smokers (18+ years old) in Atlanta, Georgia.

resultsParticipants interpreted uncertainty about health effects of e-cigarettes as an indicator of significant unknown risks, which some believed to be potentially more severe than the known effects of cigarettes (such as cancer and heart disease). Also, participants were sceptical about the lower risk claims. Some participants misinterpreted what 'switching completely' or 'switching 100% of the time' means, perceiving switching from e-cigarettes to combusted cigarettes as comparable with the use of both products. When chemicals in e-cigarettes were mentioned (eg, nicotine or formaldehyde), participants viewed e-cigarettes as very harmful and had difficulty reconciling this belief with the reduced risk claim. Comparative risk messages emphasising smoking risks were perceived as effective. Participants also appreciated being given an option to switch if they cannot quit. Participants suggested the inclusion of more facts and statistics and a credible message source (eg, public health agencies) to increase message effectiveness.

conclusionComparative risk messages may be more acceptable to smokers if they show direct comparisons of the number of toxic chemicals in cigarettes and e-cigarettes, are attributed to a credible source(s), and emphasise smoking risks.

Indexed as

Electronic Nicotine Delivery SystemsAdolescentAdultAgedCigarette SmokingCommunicationFemaleFocus GroupsGeorgiaHumansMaleMiddle AgedRiskSmokersTobacco ProductsVapingcomparative riske-cigarette messagese-cigarettesmodified risk

Identifiers

PMID31040224
PMCPMC6821570
OpenAlexW2942787269

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.